dr-lalchandani-labs-ltd

Dr Lalchandani Labs Ltd Financials
Company Logo

Dr Lalchandani Labs Ltd Financial Statement

Dr Lalchandani Labs Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Dr Lalchandani Labs Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual4.81
Operating Expenses Annual4.61
Operating Profit Annual1.63
Interest Annual0.38
Depreciation0.55
Net Profit Annual0.62
Tax AnnualTBA

Dr Lalchandani Labs Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning3.10
Cash Flow from Operations-0.22
Cash Flow from Investing1
Cash Flow from Financing-1.59
Cash Flow at the End2.29

Dr Lalchandani Labs Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)4.99
PBIT Margin (%)-7.90
PBT Margin (%)12.89
Net PROFIT Margin (%)12.89
Return On Networth / Equity (%)-8.23
Return On Networth /Employed (%)-2.68
Return On Assets (%)4.38
Total Debt / Equity (X)0.54
Asset Turnover Ratio (%)0.34

Dr Lalchandani Labs Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual3.99
Total Current Assets Annual9.48
Non Current Assets Annual5.51
Total Shareholders Funds Annual9.54
Total Assets Annual14.99

Dr Lalchandani Labs Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Dec 13, 2024, Dr Lalchandani Labs Ltd has a market capitalization of 6.81 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Dr Lalchandani Labs Ltd is debt-free with a debt-to-equity ratio of 0.36.
In FY 2023 , Dr Lalchandani Labs Ltd recorded a total revenue of approximately 4.81 Cr marking a significant milestone in the company's financial performance.
Dr Lalchandani Labs Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.4% and -0.4% annually, respectively..
Dr Lalchandani Labs Ltd's current PE ratio is 10.98.
Dr Lalchandani Labs Ltd's ROCE averaged 5.0% from the FY ending March 2022 to 2024, with a median of 7.7%. It peaked at 11.6% in March 2022, reflecting strong capital efficiency over the period..
Dr Lalchandani Labs Ltd's latest EBIT is Rs. 1 Cr, surpassing the average EBIT of Rs. 0.75 Cr over the 5 years..
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions